Geneva, July 7 -- International Clinical Trials Registry received information related to the study (KCT0012161) titled 'A Pilot study for randomized controlled trial on the effect and safety of omitting preoperative alpha-adrenergic blockade for normotensive pheochromocytoma' on June 23.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Seoul National University Hospital
Condition:
Neoplasms
Intervention:
Drug : In the control group, patients will take an oral alpha-adrenergic blocker (phenoxybenzamine or doxazosin) for a minimum of 2 weeks and up to 5 weeks prior to surgery, whereas patients in the intervention gro...